Science Explorer Back to mapMap
Discussion
Institution · Viron Therapeutics (Canada)

Most cited papers from Viron Therapeutics (Canada)

Viron Therapeutics (Canada)

What are the most cited papers from Viron Therapeutics (Canada)?

The most cited paper from Viron Therapeutics (Canada) is "The Complete DNA Sequence of Myxoma Virus" (Cheryl Cameron, Sheela Hota‐Mitchell, Ling Chen et al., 1999), with 265 citations. Next come "A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention" (70) and "Complete Genomic Sequence and Comparative Analysis ofthe Tumorigenic Poxvirus Yaba Monkey TumorVirus" (55).

Showing 22 of 22 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The Complete DNA Sequence of Myxoma Virus Cheryl Cameron, Sheela Hota‐Mitchell, Ling Chen et al. · Virology Open access Nov 1999 265
2 A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Jean‐Claude Tardif, Philippe L. L’Allier, Jean Grégoire et al. · Circulation Cardiovascular Interventions Open access 10 Nov 2010 70
3 Complete Genomic Sequence and Comparative Analysis ofthe Tumorigenic Poxvirus Yaba Monkey TumorVirus Craig R. Brunetti, Hiroko Amano, Yoshiaki Ueda et al. · Journal of Virology Open access 25 Nov 2003 55
4 Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection Erbin Dai, Li-Ying Liu, Hao Wang et al. · PLoS ONE Open access 6 May 2010 53
5 VIRAL CHEMOKINE-BINDING PROTEINS INHIBIT INFLAMMATORY RESPONSES AND AORTIC ALLOGRAFT TRANSPLANT VASCULOPATHY IN RAT MODELS Liying Liu, Erbin Dai, Leslie W. Miller et al. · Transplantation Jun 2004 51
6 Myxomavirus-Derived Serpin Prolongs Survival and Reduces Inflammation and Hemorrhage in an Unrelated Lethal Mouse Viral Infection Hao Chen, Donghang Zheng, Jeff Abbott et al. · Antimicrobial Agents and Chemotherapy Open access 18 Jun 2013 45
7 Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses Erbin Dai, Kasinath Viswanathan, Yun ming Sun et al. · Journal of Biological Chemistry Open access 10 Jan 2006 44
8 Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B Kasinath Viswanathan, Jakob Richardson, Babajide Togonu-Bickersteth et al. · Journal of Leukocyte Biology 3 Dec 2008 40
9 CHEMOKINE-BINDING VIRAL PROTEIN M-T7 PREVENTS CHRONIC REJECTION IN RAT RENAL ALLOGRAFTS Eric L.R. Bédard, Peter Kim, Jifu Jiang et al. · Transplantation Jul 2003 38
10 The Serpin Saga; Development of a New Class of Virus Derived Anti-Inflammatory Protein Immunotherapeutics Alexandra R Lucas et al. · Advances in experimental medicine and biology Book chapter 2009 38
11 Prevention of Chronic Renal Allograft Rejection by SERP-1 Protein Eric L.R. Bédard, Jifu Jiang, Jacqueline Arp et al. · Transplantation 27 Mar 2006 37
12 The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases Gary A. Skarja, Allison L. Brown, Rebecca Ka Yan Ho et al. · Biomaterials 15 Jan 2009 32
13 Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets Ganesh Munuswamy‐Ramanujam, Erbin Dai, Liying Liu et al. · Thrombosis and Haemostasis 2010 31
14 Induction of Indefinite Cardiac Allograft Survival Correlates With Toll-Like Receptor 2 and 4 Downregulation After Serine Protease Inhibitor-1 (Serp-1) Treatment Jifu Jiang, Jacqueline Arp, Dalibor Kubelik et al. · Transplantation 15 Nov 2007 27
15 Viral Serpin Therapeutics Hao Chen, Donghang Zheng, Jennifer A. Davids et al. · Methods in enzymology on CD-ROM/Methods in enzymology Book chapterOpen access 2011 19
16 Serpin Treatment Suppresses Inflammatory Vascular Lesions in Temporal Artery Implants (TAI) from Patients with Giant Cell Arteritis Hao Chen, Donghang Zheng, Sriram Ambadapadi et al. · PLoS ONE Open access 6 Feb 2015 16
17 Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus Ernest Brahn, Sarah Lee, Alexandra Lucas et al. · Clinical Immunology 17 May 2014 16
18 Supraspinal Antinociceptive Response to [d-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other δ-Agonists in the Rat Graeme L. Fraser, Amynah A. A. Pradhan, Paul B. S. Clarke et al. · Journal of Pharmacology and Experimental Therapeutics Dec 2000 15
19 Heparin Alters Viral Serpin, Serp-1, Anti-Thrombolytic Activity to Anti-Thrombotic Activity Xing Li, Heather Schneider, Andrew Raymond Peters et al. · The Open Biochemistry Journal Open access 6 Feb 2008 12
20 Upstream process optimization and its critical role in chimpanzee adenoviral vector clinical drug development: lessons learned from VRON-0200 manufacturing Larissa H. Haut, Janice Bennett, Paula MacDonald · Frontiers in Bioengineering and Biotechnology Open access 10 Sep 2026 0
21 006 Development of a Novel Matrix Metalloproteinase‐Inhibiting Wound Dressing Gary A. Skarja, Maud Gorbet, Rebecca K. Lawson‐Smith et al. · Wound Repair and Regeneration Apr 2004 0
22 40 Hao Chen, Donghang Zheng, Liying Liu et al. · Cytokine 14 Aug 2013 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.